Aspiriant LLC’s iShares ESG Optimized MSCI USA ETF SUSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.25M Sell
40,507
-1,500
-4% -$221K 0.15% 66
2026
Q1
$5.55M Hold
42,007
0.16% 65
2025
Q4
$5.85M Buy
42,007
+35,139
+512% +$4.85M 0.17% 66
2025
Q3
$932K Hold
6,868
0.03% 152
2025
Q2
$871K Hold
6,868
0.03% 156
2025
Q1
$789K Hold
6,868
0.03% 157
2024
Q4
$835K Buy
+6,868
New +$843K 0.03% 156
2024
Q3
Sell
-3,412
Closed -$383K 308
2024
Q2
$383K Buy
+3,412
New +$370K 0.02% 204

Other funds holding SUSA

Aspiriant LLC's SUSA Position: Q2 2026 in Review

Aspiriant LLC reduced its iShares ESG Optimized MSCI USA ETF (SUSA) stake by 3.6% in Q2 2026, selling an estimated $221K and leaving 40,507 shares worth $6.25M. The position accounts for 0.15% of the portfolio, ranked #66.

Aspiriant LLC first reported a position in SUSA in Q2 2024 and has held it in 8 quarters since. 532 funds tracked by Wall St. Rank hold SUSA as of Q2 2026.

  • Aspiriant LLC held 40,507 shares of iShares ESG Optimized MSCI USA ETF worth $6.25M as of Q2 2026.
  • Aspiriant LLC sold 1,500 iShares ESG Optimized MSCI USA ETF shares in Q2 2026, an estimated $221K.
  • iShares ESG Optimized MSCI USA ETF made up 0.15% of Aspiriant LLC's portfolio in Q2 2026, its #66 holding.
  • Aspiriant LLC first reported a position in iShares ESG Optimized MSCI USA ETF in Q2 2024 and has held it in 8 quarters since.
  • 532 funds tracked by Wall St. Rank held iShares ESG Optimized MSCI USA ETF as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.